Primiano Christopher Brett

Track

Insider profile

Performance

Overall performance
0.8
Performance over holding periods
0.8
30 days 90 days 120 days
Average return -9% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Primiano Christopher Brett's trades of Karyopharm Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-12-03 2020-12-01
PlS Planned sale
37,817 -3.4%
252.18
US$1,867,776 		37,817 -3.4% 252.18 US$1,867,776
2020-12-03 2020-12-01
PlS Planned sale
40,078 +16.9%
328.40
US$1,809,375 		40,078 +16.9% 328.40 US$1,809,375
2020-11-04 2020-11-02
PlS Planned sale
18,201 +44.6%
90.97
US$2,348,123 		18,201 +44.6% 90.97 US$2,348,123
2020-10-14 2020-10-13
PlS Planned sale
721 -13.4%
17.20
US$12,401 		721 -13.4% 17.20 US$12,401
2020-10-14 2020-10-13
PlS Planned sale
38,550 -89.2%
16.85
US$649,568 		38,550 -89.2% 16.85 US$649,568
2020-09-10 2020-09-08
PlS Planned sale
10,054 -68.4%
14.98
US$150,609 		10,054 -68.4% 14.98 US$150,609
2020-05-11 2020-05-07
PlS Planned sale
2,946 -38.8%
20.00
US$58,920 		2,946 -38.8% 20.00 US$58,920
2020-05-11 2020-05-07
PlS Planned sale
6,714 -59.1%
19.62
US$131,707 		6,714 -59.1% 19.62 US$131,707
2020-03-04 2020-03-02
PlS Planned sale
9,000 -46.5%
24.00
US$216,029 		9,000 -46.5% 24.00 US$216,029
2020-03-04 2020-03-02
PlS Planned sale
10,000 -34.1%
28.00
US$280,000 		10,000 -34.1% 28.00 US$280,000
2020-03-04 2020-03-02
PlS Planned sale
7,500 -20.3%
23.50
US$176,250 		7,500 -20.3% 23.50 US$176,250
2020-02-21 2020-02-19
S Sale
2,961 -22.2%
16.48
US$48,803 		2,961 -22.2% 16.48 US$48,803